Search Results - "Kim, Yeoun jin"
-
1
Reproducibility Assessment of Relative Quantitation Strategies for LC−MS Based Proteomics
Published in Analytical chemistry (Washington) (01-08-2007)“…The reproducibility of a given method for relative quantitation governs the reliability of liquid chromatography−mass spectrometry (LC−MS) based differential…”
Get full text
Journal Article -
2
The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies
Published in Scientific reports (16-08-2022)“…Mass spectrometry-based targeted proteomics allows objective protein quantitation of clinical biomarkers from a single section of formalin-fixed,…”
Get full text
Journal Article -
3
A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
Published in Molecular cancer (05-10-2018)“…Drug resistance remains an unsolved clinical issue in oncology. Despite promising initial responses obtained with BRAF and MEK kinase inhibitors, resistance to…”
Get full text
Journal Article -
4
Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays
Published in Proteomics (Weinheim) (01-09-2015)“…The quantification of plasma proteins using the high resolution and accurate mass (HR/AM)‐based parallel reaction monitoring (PRM) method provides an immediate…”
Get full text
Journal Article -
5
Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer
Published in British journal of cancer (28-08-2018)“…Background Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used…”
Get full text
Journal Article -
6
Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissue
Published in Clinical proteomics (25-10-2023)“…Background Quantification of drug-target binding is critical for confirming that drugs reach their intended protein targets, understanding the mechanism of…”
Get full text
Journal Article -
7
Mass spectrometry–based detection and quantification of plasma glycoproteins using selective reaction monitoring
Published in Nature protocols (01-05-2012)“…Mass spectrometry–based targeted proteomics is a rapidly expanding method for quantifying proteins in complex clinical samples such as plasma. In conjunction…”
Get full text
Journal Article -
8
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
Published in EBioMedicine (01-12-2020)“…Undifferentiated pleomorphic sarcoma (UPS) is the most frequent, aggressive and less-characterized sarcoma subtype. This study aims to assess UPS molecular…”
Get full text
Journal Article -
9
Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection
Published in Cancers (19-06-2020)“…Lung cancer is the deadliest cancer worldwide, mainly due to its advanced stage at the time of diagnosis. A non-invasive method for its early detection remains…”
Get full text
Journal Article -
10
Structural Mass Spectrometry in Protein Therapeutics Discovery
Published in Analytical chemistry (Washington) (01-09-2010)“…The protein therapeutics market is one of the highest growing segments of the pharmaceutical industry with an estimated global market value of $77 billion by…”
Get full text
Journal Article -
11
Analysis of Viral Glycoproteins by MALDI-TOF Mass Spectrometry
Published in Analytical chemistry (Washington) (01-04-2001)“…Membrane glycoproteins were shown to be useful biomarkers of enveloped viruses using on-target deglycosylation and matrix-assisted laser…”
Get full text
Journal Article -
12
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
Published in Blood (27-08-2015)“…Exosomes derived from solid tumor cells are involved in immune suppression, angiogenesis, and metastasis, but the role of leukemia-derived exosomes has been…”
Get full text
Journal Article -
13
Identification of 12Cysβ on tubulin as the binding site of tubulyzine
Published in Bioorganic & medicinal chemistry (15-02-2006)“…We have undertaken quantitative binding site studies in order to identify the binding site of the known microtubule destabilizing agents, the tubulyzines, in…”
Get full text
Journal Article -
14
Structural Characterization of the Molten Globule State of Apomyoglobin by Limited Proteolysis and HPLC-Mass Spectrometry
Published in Biochemistry (Easton) (24-05-2005)“…A method to characterize the structural conformation of an acidic molten globule apomyoglobin (apoMb) at pH 4.2 was developed using limited proteolysis and…”
Get full text
Journal Article -
15
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
Published in Oncotarget (25-10-2016)“…Personalized medicine has emerged as the future of cancer care to ensure that patients receive individualized treatment specific to their needs. In order to…”
Get full text
Journal Article -
16
Global Extraction from Parallel Reaction Monitoring to Quantify Background Peptides for Improved Normalization and Quality Control in Targeted Proteomics
Published in Analytical chemistry (Washington) (12-10-2021)“…Mass spectrometry-based targeted proteomics employs heavy isotope-labeled proteins or peptides as standards to improve accuracy and precision. The input sample…”
Get full text
Journal Article -
17
Targeted data-independent acquisition for mass spectrometric detection of RAS mutations in formalin-fixed, paraffin-embedded tumor biopsies
Published in Journal of proteomics (30-10-2018)“…Genomic testing for KRAS and NRAS mutations in clinical biopsies of various cancers is routinely performed to predict futility of anti-epidermal growth factor…”
Get full text
Journal Article -
18
Verification of the Biomarker Candidates for Non-small-cell Lung Cancer Using a Targeted Proteomics Approach
Published in Journal of proteome research (06-03-2015)“…Lung cancer, with its high metastatic potential and high mortality rate, is the worldwide leading cause of cancer-related deaths. High-throughput “omics”-based…”
Get full text
Journal Article -
19
CLDN18/CLDN18.2 IHC assay comparison (SP455, 43-14A, EPR19202) and co-prevalence expression with other biomarkers in gastric carcinoma
Published in Journal of clinical oncology (01-06-2024)“…4089 Background: Despite recent advances in treatment, gastric cancer (GC) remains the fourth leading cause of cancer-related mortality worldwide. Claudin 18.2…”
Get full text
Journal Article -
20
Mechanistic Insight into the Inactivation of Carboxypeptidase A by α-Benzyl-2-oxo-1,3-oxazolidine-4-acetic Acid, a Novel Type of Irreversible Inhibitor for Carboxypeptidase A with No Stereospecificity
Published in Journal of organic chemistry (21-09-2001)“…On the basis of the active site topology and enzymic catalytic mechanism of carboxypeptidase A (CPA), a prototypical zinc-containing proteolytic enzyme,…”
Get full text
Journal Article